Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine F Krammer, K Srivastava, H Alshammary, AA Amoako, MH Awawda, ... New England Journal of Medicine 384 (14), 1372-1374, 2021 | 804 | 2021 |
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron JM Carreño, H Alshammary, J Tcheou, G Singh, AJ Raskin, H Kawabata, ... Nature 602 (7898), 682-688, 2022 | 450 | 2022 |
SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals K Sano, D Bhavsar, G Singh, D Floda, K Srivastava, C Gleason, ... Nature Communications 13 (1), 5135, 2022 | 79 | 2022 |
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains B Ying, B Whitener, LA VanBlargan, AO Hassan, S Shrihari, CY Liang, ... Science translational medicine 14 (630), eabm3302, 2021 | 66 | 2021 |
mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations JM Carreño, G Singh, J Tcheou, K Srivastava, C Gleason, H Muramatsu, ... Vaccine 40 (42), 6114-6124, 2022 | 40 | 2022 |
Morphometric analysis of foramen magnum in human skull for sex determination G Singh, I Talwar Human biology review 2 (1), 29-41, 2013 | 39 | 2013 |
Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients JM Carreño, H Alshammary, G Singh, A Raskin, F Amanat, A Amoako, ... EBioMedicine 73, 2021 | 38 | 2021 |
Safety and immunogenicity of a newcastle disease virus vector-based SARS-CoV-2 vaccine candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs JH Lara-Puente, JM Carreño, W Sun, A Suárez-Martínez, ... MBio 12 (5), 10.1128/mbio. 01908-21, 2021 | 35 | 2021 |
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study A Ozonoff, J Schaenman, ND Jayavelu, CE Milliren, CS Calfee, CB Cairns, ... EBioMedicine 83, 2022 | 33 | 2022 |
Determination of gender differences from fingerprints ridge density in two northern Indian population of Chandigarh region G Singh J. Forensic Res 3 (03), 3, 2012 | 22 | 2012 |
Bivalent COVID-19 booster vaccines and the absence of BA. 5-specific antibodies JM Carreño, G Singh, V Simon, F Krammer The Lancet Microbe 4 (8), e569, 2023 | 20 | 2023 |
Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice I González-Domínguez, JL Martínez, S Slamanig, N Lemus, Y Liu, TY Lai, ... Microbiology Spectrum 10 (3), e01538-22, 2022 | 19 | 2022 |
Analysis of ANKKI (rs1800497) and DRD2 (rs1079597, rs1800498) variants in five ethnic groups from Punjab, North-West India G Singh, I Talwar, R Sharma, HS Sandhu, K Matharoo, AJS Bhanwer Gene 584 (1), 69-74, 2016 | 17 | 2016 |
Safety and immunogenicity analysis of a Newcastle disease virus (NDV-HXP-S) expressing the spike protein of SARS-CoV-2 in sprague dawley rats J Tcheou, A Raskin, G Singh, H Kawabata, D Bielak, W Sun, ... Frontiers in Immunology 12, 791764, 2021 | 16 | 2021 |
Genetic differentiation and population structure of five ethnic groups of Punjab (North-West India) G Singh, I Talwar, R Sharma, K Matharoo, AJS Bhanwer Molecular Genetics and Genomics 291, 2055-2063, 2016 | 15 | 2016 |
Identification of selected wild felids using hair morphology and forensically informative nucleotide sequencing (FINS): Wildlife forensics prospective G Singh, Y Srinivas, GC Kumar, A Singh, CP Sharma, SK Gupta Legal Medicine 44, 101692, 2020 | 12 | 2020 |
Longitudinal analysis of severe acute respiratory syndrome coronavirus 2 seroprevalence using multiple serology platforms FK Juan Manuel Carreño, Damodara Rao Mendu, Viviana Simon, Masood A Shariff ... iScience 24 (9), 1-12, 2021 | 8 | 2021 |
SARS-CoV-2 spike-binding antibody longevity and protection from reinfection with antigenically similar SARS-CoV-2 variants J Kubale, C Gleason, JM Carreño, K Srivastava, G Singh, A Gordon, ... MBio, 2022 | 6 | 2022 |
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants S Changrob, PJ Halfmann, H Liu, JL Torres, JJC McGrath, G Ozorowski, ... The Journal of Clinical Investigation 133 (8), 2023 | 5 | 2023 |
Binding and avidity signatures of polyclonal sera from individuals with different exposure histories to severe acute respiratory syndrome coronavirus 2 infection, vaccination … G Singh, A Abbad, J Tcheou, DR Mendu, A Firpo-Betancourt, C Gleason, ... The Journal of Infectious Diseases 228 (5), 564-575, 2023 | 4 | 2023 |